August J. Troendle

Filings by August J. Troendle span 2 companies, the busiest being Medpace Holdings, Inc. and Coherus Oncology, Inc. In total, 112 filings cover trades dated from 9 February 2016 to 30 September 2026.

On the open market, the record shows 10 purchases worth €80.8M and 99 sales worth €649.7M. On balance, insiders were net sellers of €568.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 option exercises. So far in 2026, the count stands at no purchases and 24 sales.

A typical purchase (the median) is worth €9.0M. Of 10 purchases, 10 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +32.9%. These figures describe past trades and do not predict future prices.

The record was last updated on 1 October 2026 with an open-market sale (€14.6M) in Medpace Holdings, Inc. The last insider purchase was made public on 23 September 2022, 1,486 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.